TrialBlood advances2023

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.

Antoine N Saliba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.